Endocrinol Metab Clin North Am 26: 189-218 Bjoro T, Holmen J, Kruger O, Midthjell K, Hunstad K, et al
4.9% placebo) 32.0% lost at least 20% (vs
Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality
Correcting B12 changes your metabolism and nervous-system signalling, and that adjustment itself can feel like tiredness, lightheadedness or a vague off feeling before things settle
There are various oligonucleotide therapy (ONT) agents (such as antisense, deoxyribozymes, siRNA and CRISPR/Cas) that offer promising therapeutic tools.A variation of gene therapy, oligonucleotide gene therapies (OGTs) are manufactured using synthetic oligonucleotides